Prevention and treatment of osteoporosis in inflammatory bowel disease

Gary R. Lichtenstein; Bruce E. Sands; Michael Pazianas

doi:10.1097/00054725-200608000-00016

Prevention and treatment of osteoporosis in inflammatory bowel disease

Gary R. Lichtenstein, Bruce E. Sands, Michael Pazianas

Research output: Contribution to journal › Review article › peer-review

86 Scopus citations

Abstract

The following are guidelines for evaluation and consideration for treatment of patients with inflammatory bone disease (IBD) after bone mineral density (BMD) measurements. The Crohn's & Colitis Foundation of America (CCFA) has indicated that its recommendations are intended to serve as reference points for clinical decision-making, not as rigid standards, limits, or rules. They should not be interpreted as quality standards.

Original language	English
Pages (from-to)	797-813
Number of pages	17
Journal	Inflammatory Bowel Diseases
Volume	12
Issue number	8
DOIs	https://doi.org/10.1097/00054725-200608000-00016
State	Published - Aug 2006
Externally published	Yes

Keywords

CCFA Guidelines

Access to Document

10.1097/00054725-200608000-00016

Cite this

@article{ab7dba6ba44e4f16bcdbaac7d312069f,

title = "Prevention and treatment of osteoporosis in inflammatory bowel disease",

abstract = "The following are guidelines for evaluation and consideration for treatment of patients with inflammatory bone disease (IBD) after bone mineral density (BMD) measurements. The Crohn's & Colitis Foundation of America (CCFA) has indicated that its recommendations are intended to serve as reference points for clinical decision-making, not as rigid standards, limits, or rules. They should not be interpreted as quality standards.",

keywords = "CCFA Guidelines",

author = "Lichtenstein, {Gary R.} and Sands, {Bruce E.} and Michael Pazianas",

year = "2006",

month = aug,

doi = "10.1097/00054725-200608000-00016",

language = "English",

volume = "12",

pages = "797--813",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Prevention and treatment of osteoporosis in inflammatory bowel disease

AU - Lichtenstein, Gary R.

AU - Sands, Bruce E.

AU - Pazianas, Michael

PY - 2006/8

Y1 - 2006/8

N2 - The following are guidelines for evaluation and consideration for treatment of patients with inflammatory bone disease (IBD) after bone mineral density (BMD) measurements. The Crohn's & Colitis Foundation of America (CCFA) has indicated that its recommendations are intended to serve as reference points for clinical decision-making, not as rigid standards, limits, or rules. They should not be interpreted as quality standards.

AB - The following are guidelines for evaluation and consideration for treatment of patients with inflammatory bone disease (IBD) after bone mineral density (BMD) measurements. The Crohn's & Colitis Foundation of America (CCFA) has indicated that its recommendations are intended to serve as reference points for clinical decision-making, not as rigid standards, limits, or rules. They should not be interpreted as quality standards.

KW - CCFA Guidelines

UR - http://www.scopus.com/inward/record.url?scp=33747418927&partnerID=8YFLogxK

U2 - 10.1097/00054725-200608000-00016

DO - 10.1097/00054725-200608000-00016

M3 - Review article

C2 - 16917235

AN - SCOPUS:33747418927

SN - 1078-0998

VL - 12

SP - 797

EP - 813

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 8

ER -

Prevention and treatment of osteoporosis in inflammatory bowel disease

Abstract

Keywords

Access to Document

Fingerprint

Cite this